
Keywords: RepliVax; Rabies vaccine; Flavivirus vector; Replication defective; Preclinical; CV-WN; ChimeriVax®-West Nile; DEN; dengue; HC; helper cells; LAV; live attenuated vaccine; prM; precursor for mature M protein; RabG; rabies virus glycoprotein G; RV; RepliV